Dipal Doshi's most recent trade in Entrada Therapeutics Inc was a trade of 173,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 173,400 | 173,400 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 116,200 | 441,953 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. | 01 Mar 2025 | 17,566 | 424,387 | - | 11.7 | 205,146 | Common Stock |
| Azenta Inc | Dipal Doshi | Director | Grant, award, or other acquisition of securities at price $ 52.32 per share. | 07 Feb 2025 | 4,040 | 4,040 (0%) | 0% | 52.3 | 211,373 | Common |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. | 03 Sep 2024 | 4,744 | 326,579 | - | 15.4 | 73,169 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. | 03 Sep 2024 | 2,328 | 332,147 | - | 15.8 | 36,692 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 03 Sep 2024 | 826 | 325,753 | - | 15.1 | 12,494 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.93 per share. | 03 Sep 2024 | 752 | 331,395 | - | 16.9 | 12,728 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.71 per share. | 03 Sep 2024 | 72 | 331,323 | - | 17.7 | 1,275 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 17.81 per share. | 12 Jul 2024 | 1,600 | 334,475 | - | 17.8 | 28,497 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 12 Jul 2024 | 300 | 336,075 | - | 18 | 5,400 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 16.17 per share. | 13 Jun 2024 | 1,000 | 336,375 | - | 16.2 | 16,174 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 May 2024 | 1,800 | 338,575 | - | 15 | 27,000 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 16 May 2024 | 1,200 | 337,375 | - | 15.1 | 18,129 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 158,500 | 158,500 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 104,700 | 347,979 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. | 01 Mar 2024 | 5,049 | 340,375 | - | 12.3 | 61,996 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. | 01 Mar 2024 | 1,391 | 345,424 | - | 13.4 | 18,594 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. | 01 Mar 2024 | 1,164 | 346,815 | - | 12.4 | 14,460 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 15 Feb 2024 | 1,000 | 243,279 | - | 15 | 15,000 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, CEO | Sale of securities on an exchange or to another person at price $ 15.99 per share. | 16 Jan 2024 | 1,000 | 244,279 | - | 16.0 | 15,990 | Common Stock |
| Entrada Therapeutics Inc | Doshi Dipal | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 20 Dec 2023 | 1,000 | 245,279 | - | 15 | 15,000 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.23 per share. | 13 Nov 2023 | 1,000 | 246,279 | - | 16.2 | 16,230 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.67 per share. | 14 Aug 2023 | 1,000 | 201,069 | - | 15.7 | 15,671 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.71 per share. | 27 Apr 2023 | 2,000 | 202,069 | - | 13.7 | 27,422 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 17 Apr 2023 | 2,092 | 204,069 | - | 18.0 | 37,675 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.63 per share. | 27 Mar 2023 | 1,800 | 256,011 | - | 14.6 | 26,333 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.51 per share. | 27 Mar 2023 | 200 | 255,811 | - | 15.5 | 3,102 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 75,250 | 75,250 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 49,650 | 206,161 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 28 Feb 2023 | 2,000 | 161,835 | - | 12 | 24,000 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 27 Jan 2023 | 2,000 | 163,835 | - | 12.0 | 24,001 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 09 Jan 2023 | 2,410 | 165,835 | - | 15.0 | 36,196 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 27 Dec 2022 | 9,069 | 173,166 | - | 15.0 | 136,383 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 27 Dec 2022 | 4,521 | 168,645 | - | 15.0 | 67,852 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.80 per share. | 27 Dec 2022 | 600 | 182,235 | - | 14.8 | 8,879 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 27 Dec 2022 | 400 | 168,245 | - | 15.0 | 6,005 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.91 per share. | 28 Nov 2022 | 2,000 | 182,835 | - | 13.9 | 27,826 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.76 per share. | 25 Oct 2022 | 7,506 | 188,335 | - | 20.8 | 155,808 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 25 Oct 2022 | 3,055 | 195,841 | - | 20.0 | 61,127 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.66 per share. | 25 Oct 2022 | 2,000 | 184,835 | - | 21.7 | 43,325 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 25 Oct 2022 | 1,500 | 186,835 | - | 21.5 | 32,251 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.28 per share. | 20 Oct 2022 | 2,786 | 201,238 | - | 18.3 | 50,917 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.65 per share. | 20 Oct 2022 | 1,241 | 198,896 | - | 19.6 | 24,380 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.90 per share. | 20 Oct 2022 | 1,101 | 200,137 | - | 18.9 | 20,809 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 20 Oct 2022 | 811 | 204,024 | - | 18.0 | 14,607 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 26 Sep 2022 | 3,453 | 208,886 | - | 15.0 | 51,934 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.23 per share. | 26 Sep 2022 | 3,085 | 204,835 | - | 15.2 | 46,997 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.22 per share. | 26 Sep 2022 | 2,795 | 212,627 | - | 15.2 | 42,530 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 26 Sep 2022 | 966 | 207,920 | - | 15.8 | 15,286 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.30 per share. | 26 Sep 2022 | 288 | 212,339 | - | 16.3 | 4,695 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.12 per share. | 21 Sep 2022 | 3,402 | 216,445 | - | 15.1 | 51,425 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 21 Sep 2022 | 1,023 | 215,422 | - | 15.1 | 15,413 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 15 Sep 2022 | 200 | 219,847 | - | 15.0 | 3,008 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.16 per share. | 08 Sep 2022 | 1,100 | 220,735 | - | 15.2 | 16,673 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 08 Sep 2022 | 688 | 220,047 | - | 15.1 | 10,366 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 15,125 | 221,835 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.56 per share. | 29 Aug 2022 | 1,109 | 207,601 | - | 12.6 | 13,931 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.51 per share. | 29 Aug 2022 | 505 | 207,096 | - | 13.5 | 6,822 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 29 Aug 2022 | 190 | 206,881 | - | 12 | 2,280 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 29 Aug 2022 | 171 | 206,710 | - | 12 | 2,052 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 29 Aug 2022 | 25 | 207,071 | - | 14 | 350 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 27 Jul 2022 | 2,000 | 208,710 | - | 12 | 24,000 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 90,750 | 90,750 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 27 Jun 2022 | 4,000 | 210,710 | - | 12 | 48,000 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 181,500 | 181,500 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 30,250 | 214,710 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 13 Jan 2022 | 10,000 | 184,460 | - | 1.7 | 17,400 | Common Stock |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 10,000 | 399,989 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Dipal Doshi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 184,821 | 184,821 | - | - | Stock Option (Right to Buy) |